Oxyprothepine decanoate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581897

CAS#: 41931-86-6

Description: Oxyprothepine decanoate is a biochemical.

Chemical Structure

Oxyprothepine decanoate
CAS# 41931-86-6

Theoretical Analysis

MedKoo Cat#: 581897
Name: Oxyprothepine decanoate
CAS#: 41931-86-6
Chemical Formula: C32H46N2O2S2
Exact Mass: 554.3001
Molecular Weight: 554.85
Elemental Analysis: C, 69.27; H, 8.36; N, 5.05; O, 5.77; S, 11.56

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Oxyprothepine decanoate; Oxyprothepin-decanoate; Oxyprothepin decanoate; Oxyprothepine-decanoate.

IUPAC/Chemical Name: 3-(4-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)piperazinyl)propyl decanoate


InChi Code: InChI=1S/C32H46N2O2S2/c1-3-4-5-6-7-8-9-15-32(35)36-23-12-18-33-19-21-34(22-20-33)29-24-26-13-10-11-14-30(26)38-31-17-16-27(37-2)25-28(29)31/h10-11,13-14,16-17,25,29H,3-9,12,15,18-24H2,1-2H3


Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 554.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Cesková E, Svestka J, Rysánek R. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses]. Cesk Psychiatr. 1993 Jan;89(1):11-4. Czech. PubMed PMID: 8099534.

2: Buresová A, Bártová D, Svestka J. Comparison of pharmacotherapeutic procedures in the treatment of sexual deviant behaviour. Act Nerv Super (Praha). 1990 Dec;32(4):299-301. PubMed PMID: 1982035.

3: Bártová D, Buresová A, Hajnová R, Svestka J, Tichý P. [The effect of oxyprothepine decanoate, lithium and cyproterone acetate on deviant sexual behavior]. Cesk Psychiatr. 1986 Dec;82(6):355-60. Czech. PubMed PMID: 2879643.

4: David I, Filip V, Hellerová P. [Substitution of fluphenazine decanoate with oxyprothepine decanoate in long-term maintenance therapy in schizophrenia]. Cesk Psychiatr. 1986 Oct;82(5):313-7. Czech. PubMed PMID: 2878734.

5: Filip V, Faltus F, Hanáková S, Janecková E, Raboch J, Dobiásová A, Karen P, Posmurová M. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study]. Cesk Psychiatr. 1985 Feb;81(1):6-14. Czech. PubMed PMID: 2858269.

6: Balon R, Kabesh Ia, Papezhova G. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1982;82(1):116-8. Russian. PubMed PMID: 6121437.

7: Kalvach Z, Hálková E, Bastecký J. Further clinical experience with oxyprothepin-decanoate. Act Nerv Super (Praha). 1981 Dec;23(4):271-2. PubMed PMID: 6121440.

8: Kabes J, Balon R, Hanzlícek L, Skovajsová M, Kozáková H. [Clinical trial of oxyprothepin decanoate (author's transl)]. Cesk Psychiatr. 1980 Feb;76(1):16-25. Czech. PubMed PMID: 6103755.